» Articles » PMID: 17307213

Point Mutations in EBV GH That Abrogate or Differentially Affect B Cell and Epithelial Cell Fusion

Overview
Journal Virology
Specialty Microbiology
Date 2007 Feb 20
PMID 17307213
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Cell fusion mediated by Epstein-Barr virus requires three conserved glycoproteins, gB and gHgL, but activation is cell type specific. B cell fusion requires interaction between MHC class II and a fourth virus glycoprotein, gp42, which complexes non-covalently with gHgL. Epithelial cell fusion requires interaction between gHgL and a novel epithelial cell coreceptor and is blocked by excess gp42. We show here that gp42 interacts directly with gH and that point mutations in the region of gH recognized by an antibody that differentially inhibits epithelial and B cell fusion significantly impact both the core fusion machinery and cell-specific events. Substitution of alanine for glycine at residue 594 completely abrogates fusion with either B cells or epithelial cells. Substitution of alanine for glutamic acid at residue 595 reduces fusion with epithelial cells, greatly enhances fusion with B cells and allows low levels of B cell fusion even in the absence of gL.

Citing Articles

Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition.

Chen W, Kim J, Bu W, Board N, Tsybovsky Y, Wang Y Immunity. 2022; 55(11):2135-2148.e6.

PMID: 36306784 PMC: 9815946. DOI: 10.1016/j.immuni.2022.10.003.


Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV.

Kim J, Bu W, Mine S, Tariq Z, Nguyen H, Wang Y Virology. 2021; 561:80-86.

PMID: 34171765 PMC: 8803478. DOI: 10.1016/j.virol.2021.06.006.


Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells.

Bu W, Joyce M, Nguyen H, Banh D, Aguilar F, Tariq Z Immunity. 2019; 50(5):1305-1316.e6.

PMID: 30979688 PMC: 6660903. DOI: 10.1016/j.immuni.2019.03.010.


Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies.

Sathiyamoorthy K, Jiang J, Mohl B, Chen J, Zhou Z, Longnecker R Proc Natl Acad Sci U S A. 2017; 114(41):E8703-E8710.

PMID: 28939750 PMC: 5642686. DOI: 10.1073/pnas.1704661114.


The Cytoplasmic Tail Domain of Epstein-Barr Virus gH Regulates Membrane Fusion Activity through Altering gH Binding to gp42 and Epithelial Cell Attachment.

Chen J, Jardetzky T, Longnecker R mBio. 2016; 7(6).

PMID: 27935841 PMC: 5111410. DOI: 10.1128/mBio.01871-16.


References
1.
Moss B, Elroy-Stein O, Mizukami T, Alexander W, Fuerst T . Product review. New mammalian expression vectors. Nature. 1990; 348(6296):91-2. DOI: 10.1038/348091a0. View

2.
Gianni T, Forghieri C, Campadelli-Fiume G . The herpesvirus glycoproteins B and H.L are sequentially recruited to the receptor-bound gD to effect membrane fusion at virus entry. Proc Natl Acad Sci U S A. 2006; 103(39):14572-7. PMC: 1600001. DOI: 10.1073/pnas.0606127103. View

3.
Spear P, Longnecker R . Herpesvirus entry: an update. J Virol. 2003; 77(19):10179-85. PMC: 228481. DOI: 10.1128/jvi.77.19.10179-10185.2003. View

4.
Borza C, Morgan A, Turk S, Hutt-Fletcher L . Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J Virol. 2004; 78(10):5007-14. PMC: 400351. DOI: 10.1128/jvi.78.10.5007-5014.2004. View

5.
Lopper M, Compton T . Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion. J Virol. 2004; 78(15):8333-41. PMC: 446119. DOI: 10.1128/JVI.78.15.8333-8341.2004. View